98 -11 (73) 2024 - Atkhamova Sh.R., Kurbanov B.B. - MORPHOFUNCTIONAL FEATURES OF THE PLACENTA AND PLACENTAL SITE IN WOMEN WITH PREECLAMPSIA OF VARYING DEGREES

MORPHOFUNCTIONAL FEATURES OF THE PLACENTA AND PLACENTAL SITE IN WOMEN WITH PREECLAMPSIA OF VARYING DEGREES

Atkhamova Sh.R. - Tashkent Pediatric Medical Institute

Kurbanov B.B. - Tashkent Pediatric Medical Institute

Resume

To date, the results of most researchers come down to the fact that the basis for the development of preeclampsia is a pathological change in the processes of implantation and placentation, the first manifestation of which is a violation of the migration of cytotrophoblast cells in the initial period of pregnancy, which subsequently causes pathological changes in the function of the vascular endothelium. This article presents the main morphological elements of the placenta in women with preeclampsia of varying degrees.

Keywords: Preeclampsia, placenta, morphology.

First page

567

Last page

579

For citation:Atkhamova Sh.R., Kurbanov B.B. - MORPHOFUNCTIONAL FEATURES OF THE PLACENTA AND PLACENTAL SITE IN WOMEN WITH PREECLAMPSIA OF VARYING DEGREES//New Day in Medicine 11(73)2024 567-579 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024

List of References

  1. Ихьтиярова Г. А., Негматуллаева М. Н., Туксанова Д. И. Современные аспекты коррекции гемодинамических нарушений у родильниц с преэклампсией легкой степени //Педиатрия (узб). 2003; Спец. вып. -С. 97-99.
  2. Захидова Н. Э., Хегай Т. Р., Арипова Т. У. Мета-анализ факторов риска развития преэклампсии //Журнал теоретической и клинической медицины. 2018;2:72-76.
  3. Абдурахманова Д. Н., Мадаминова М. Ш., Садуллаева А. Ф. Преэклампсия-актуальная проблема в современном акушерстве //International scientific review. 2016;5(15).
  4. Мирзаева Д. Б. Особенности течения родов у женщин с тяжелой преэклампсией //Вестник Российского государственного медицинского университета. 2015;2:50-51.
  5. Курбанов Б. Б. Морфофункциональные изменения плаценты и их взаимосвязь с уровнем белка Sflt1 в крови беременных с преэклампсиями различной степени //Вестник экстренной медицины. 2020;13(1-2):87-91.
  6. Cerdeira A.S., Karumanchi S.A. Angiogenic proteins as aid in the diagnosis preeclampsia. //Scandinavian Journal of Clinical and Laboratory Investigation 2010;70(242):73-78.
  7. Myers J.E., Kenny L.C., McCowan L.M., Chan E.H., Dekker G.A., Poston L., Simpson N.A., North R.A. SCOPE consortium. Angiogenic factors combined with clinical risk factors to predict preterm preeclampsia in nulliparous women: a predictive test accuracy study. //BJOG 2013;120(10):1215-1223.
  8. Pabinger I., Grafenhofer H. Anticoagulation during pregnancy //Stmin Thromb Hemost. 2003;29(6):633-638.
  9. Rai R. Is miscarrige a coagulopathy? //Curr Opin Obstet Gynec. 2003;15(3):265-268.
  10. Robertson L., Wu O., Landhome P. Thrombophilia in pregnancy: a systematic review //Br J Haemat. 2006;132(2):171-196.
  11. Sakawi Y., Tarpey M., Chen Y. Eavluation of low-dose endotoxin administration during pregnancy as s model of pereclampsia //Anesthesiol. 2000;93(6):1446-1455.
  12. Srp B., Velebil P., Kvasnicka J. Fatal complications in pre-eclampsia and eclampsia //Ceska Gynec. 2002;67(6):365-371.
  13. Tanjung M., Siddik H., Hariman H. Coagulation and fibrinolysis in preeclampsia and neonates //Clin Appl Thromb Hemost. 2006;11(4):467-473.
  14. Verlohren S, Herraiz I, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. //Am J Obstet Gynecol. 2012;206(1):58.e1-8.
  15. Wijk M. van, Boer K., Berckmans R. Enhanced coagulation activation in preeclampsia: The role of APC resistance, mivropraticles and other plasma consistuents //Thromb hatvost. 2002;88(3):415-420.
  16. Yamasaki M. Preeclampsia, eclampsia //Ippon Rinsho. 2004;62(5):523-528.
  17. Young B.C., Levine R.J., Karumanchi S.A. Pathogenesis of preeclampsia. Annu Rev Pathol 2010;5:173-192.
  18. Uzan J., Carbonnel M., Piconne О., Asmar R., Ayoubi J.-M. Preeclampsia: pathophysiology, diagnosis and management. //Vascular health and risk management 2011;7:467-474.
  19. Verlohren S., Galindo A., Schlembach D., Zeisler H., Herraiz I., Moertl M.G., Pape J., Dudenhausen J.W., Denk B., Stepan H. An automated method for the determination of the sFlt-1/PIGF ratio in the assessmen t of preeclampsia. //Am J Obstet Gynecol 2010;202:2:161.e1—161.e11.

    file

    download